[1] |
HUANG Cuili, GAO Ao, WANG Jiaxi, GUO Haili, XU Xiaohan, CHENG Yinchu, GUO Daihong.
Automatic monitoring and assessment of antibiotics-related thrombocytopenia
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 807-811.
|
[2] |
DU Ying, XIE Yanming, WANG Lianxin, GENG Hongjiao, LI Xiangjie.
Clinical characteristics and drug combination analysis of Lianhua Qingwen capsules (granules) in the real world
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 296-300.
|
[3] |
WANG Yu, HUANG Jingyi, HOU Lixin, LI Shuang, CUI Yongkang, HUANG Lanwei.
Humoral immune characteristics of peripheral blood of CAP patients with antibiotic-associated DILI
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 132-135.
|
[4] |
ZHENG Jinfeng, WANG Jinghong.
Pharmaceutical care of one case of malignant arrhythmia induced by multidrug combination
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1279-1281.
|
[5] |
HUANG Yanli, XIE Yanming, WANG Lianxin, SUN Linxi, LIU Huan, ZHUANG Yunni.
Clinical applications of Ciwujia injection in elderly patients in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 935-939.
|
[6] |
DONG Hanshuo, SUN Li, ZHAO Xiaoxiao, WANG Lianxin, YU Xiaokang, XIE Yanming.
Clinical characteristics and drug combination analysis of elemene injectable emulsion in the elderly in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 845-850.
|
[7] |
XIANG Yufang, SUN Hui, CHEN Yue, WANG Ningsheng, LUO Shishu, ZHANG Zhi, FENG Bianling.
Medication safety and combined medication in patients with type 2 diabetes mellitus
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 313-316.
|
[8] |
WEI Yuanyuan, LI Fang, TAO Xiaomei, GU Hongyan.
Prevention of Adverse Reactions of Antibiotics in a Respiratory Department
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(11): 1083-1086.
|
[9] |
CHENG Jinlian, OUYANG Huitian, JIN Hongtao, ZHU Xueqi, XIAO Shuang, LEI Xiang, GAO Chunsheng, LIU Qingquan.
Thoughts and Suggestions on Safety Evaluation of Combined use of Traditional Chinese Medicine in Clinical Research
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(1): 4-10.
|
[10] |
YUAN Shoujun.
Mathematical Flaws of Commonly Used Calculating Methods of Multi-drug Combination and Solution Based on One Belt and One Line Model Method
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(1): 11-17.
|
[11] |
ZENG Huansi, ZHONG Caini, ZHONG Yilin, PENG Chenchen, ZHANG Xuan.
Analysis of 129 Cases of Adverse Reactions and Clinical Application of Plasma Concentration Monitoring of Olanzapine
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(11): 818-822.
|
[12] |
GONG Yu, ZHENG Zhixin, JING Tianchuang, SU Dan.
Analysis of One Case of Severe Pneumonia in The Elderly Complicated with Drug Fever Induced by Vancomycin
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(11): 845-847.
|
[13] |
CHEN Chong, GE Ziruo, WANG Lin, CHEN Zhihai.
Analysis and Prospect of Domestic and Foreign Plague Antibacterial Treatment Plan
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(1): 1-5.
|
[14] |
LI Yiqun, SUN Zhenxiao.
Study Progress of Norcantharidin Based Structural Modification and Drug Combination for Cancer
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(3): 179-184.
|
[15] |
PAN Weirong, SHEN Xian, SUN Sixian, ZHU Xuying.
Antibiotic Application of Myasthenia Gravis Complicated with Infection
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(10): 625-631.
|